more
First Look at Psychedelic Therapy in Australia
Cybin Receives FDA Clearance to Initiate Phase 2a Study of DMT Molecule for Anxiety
Compass Pathways Forges Research Collaboration with Hackensack Meridian Health
Johns Hopkins Professor Matthew Johnson Joins Sheppard Pratt’s Psilocybin Research Center
